Rituximab
![PDF] The epitope recognized by rituximab. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6f42276ab0369b00580794ea75979d89babf37fe/3-Table2-1.png "PDF] The epitope recognized by rituximab. | Semantic Scholar")
PDF] The epitope recognized by rituximab. | Semantic Scholar
Results of middle-down analysis of rituximab digested with GingisKHAN... | Download Scientific Diagram
Amino acid sequence of heavy chain (top) and light chain (bottom)... | Download Scientific Diagram
The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations | Blood Cancer Journal
Use of rituximab in paediatric nephrology | Archives of Disease in Childhood
RCSB PDB - 4KAQ: Structure of rituximab Fab
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab | Science
WO2019229677A1 - Anti-cd37 immunoconjugate dosing regimens - Google Patents
Sequence analysis of Rituximab-VH. Contributions to the total score are... | Download Scientific Diagram
Molecules | Free Full-Text | Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
Human Anti-CD20 monoclonal IgG1 antibody | Rituximab for R&D | InvivoGen
Amino acid sequence of rituximab heavy and light chains. The papain... | Download Scientific Diagram
Validated LC/MS Bioanalysis of Rituximab CDR Peptides Using Nano-surface and Molecular-Orientation Limited (nSMOL) Proteolysis. | Semantic Scholar
a) Cartoon representation of CD20. The four transmembrane domains are... | Download Scientific Diagram
The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine | PLOS ONE
Application Note: Characterization of Rituximab by Conformational Epitope
Figure 3 | Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity
![PDF] The epitope recognized by rituximab. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6f42276ab0369b00580794ea75979d89babf37fe/2-Table1-1.png "PDF] The epitope recognized by rituximab. | Semantic Scholar")
PDF] The epitope recognized by rituximab. | Semantic Scholar
R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study - The Lancet Haematology
STIM1 knock‐down decreases the affinity of obinutuzumab for CD20 by altering CD20 localization to Triton‐soluble membrane - Heo - 2020 - Clinical & Experimental Immunology - Wiley Online Library
Cellular and molecular signal transduction pathways modulated by rituximab ( rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention | Oncogene
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial - The Lancet Rheumatology
